CAROLYN R. BERTOZZI, PH.D.

Corporate Board Profile

Tech Score: 0/100

ALNYLAM PHARMACEUTICALS, INC.

Filing Date	Source Excerpt
2024-04-01	Dr. Bertozzi has served as the Anne T. and Robert M. Bass Professor of Chemistry at Stanford University since 2015 and as the Baker Family Director of Stanford’s Sarafan ChEM-H Institute since 2021.
2025-03-24	Dr. Bertozzi is a pioneer for emerging technology and has founded several biopharmaceutical companies and guided more than a dozen academic and professional organizations and life sciences companies in leadership and board positions. Her deep technical and leadership expertise, as well as her corporate governance experience in the biopharmaceutical industry, enables her to make significant contributions to our board, and nominating and corporate governance and science and technology committees.

Filing Date

Source Excerpt

2024-04-01

Dr. Bertozzi has served as the Anne T. and Robert M. Bass Professor of Chemistry at Stanford University since 2015 and as the Baker Family Director of Stanford’s Sarafan ChEM-H Institute since 2021.

2025-03-24

Dr. Bertozzi is a pioneer for emerging technology and has founded several biopharmaceutical companies and guided more than a dozen academic and professional organizations and life sciences companies in leadership and board positions. Her deep technical and leadership expertise, as well as her corporate governance experience in the biopharmaceutical industry, enables her to make significant contributions to our board, and nominating and corporate governance and science and technology committees.

ELI LILLY & Co

Filing Date	Source Excerpt
2021-03-19	Carolyn R. Bertozzi, Ph.D. Age: 54, Director since 2017, Board Committees: Ethics and Compliance;Science and Technology

Data sourced from SEC filings. Last updated: 2026-02-03